ESR1 and breast cancer: Breast cancers are heterogeneous and dynamic diseases classified into molecularly distinct subtypes based on the expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), which influence the clinical outcomes and the therapeutic approaches [1].